UK Prospective Diabetes Study

Publications (n=105)

Years : 2013 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1991 | 1990 | 1988 | 1985 | 1983


	UKPDS Temporal Validation of the UKPDS Outcomes Model Using 10-Year Posttrial Monitoring Data Leal J, Hayes AJ, Gray AM, Holman RR, Clarke PM. Diabetes Care 2012; (online) [Full text]

2013	UKPDS Prognostic Significance of Silent Myocardial Infarction in Newly-Diagnosed Type 2 Diabetes: UKPDS 79 Timothy M.E. Davis; Ruth L. Coleman; Rury R. Holman Circulation 2013;127:980-987 [Full text]

2009	UKPDS Letter Addition of Insulin to Oral Therapy in Type 2 Diabetes Holman RR, Matthews DM, Neil HAW N Eng J Med 2009;360:418

2008	UKPDS 81 Long-Term Follow-up after Tight Control of Blood Pressure in Type 2 Diabetes Rury R. Holman, Sanjoy K. Paul, M. Angelyn Bethel, H. Andrew W. Neil and David R. Matthews N Eng J Med 2008;359:1565-76 [Full text] [Slides]

	UKPDS 80 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes Rury R. Holman, Sanjoy K. Paul, M. Angelyn Bethel, David R. Matthews and H. Andrew W. Neil N Eng J Med 2008;359:1577-89 [Full text] [Slides]

2007	UKPDS Metformin as First Choice in oral Diabetes Treatment: the UKPDS experience Holman R Journ Annu Diabetol Hotel Dieu 2007;13:13-20 [Full text]

	UKPDS 78 Impact of the Metabolic Syndrome on Macrovascular and Microvascular Outcomes in Type 2 Diabetes Mellitus. UKPDS 78 Carole A. Cull, Christine C. Jensen, Ravi Retnakaran and Rury R. Holman Circulation 2007;116:2119-2126 [Full text] [Abstract]

	UKPDS An Association Analysis of the HLA Gene Region in Latent Autoimmune Diabetes in Adults M. Desai, E. Zeggini, V. A. Horton, K. R. Owen, A. T. Hattersley, J. C. Levy, M. Walker, K. M. Gillespie, P. J. Bingley, G. A. Hitman, R. R. Holman, M. I. McCarthy and A. Clark Diabetologia 2007;50:68-73 [Full text] [Abstract]

2006	UKPDS 76 Paraoxonase2 (PON2) Polymorphisms and Development of Renal Dysfunction in Type 2 Diabetes: UKPDS 76 Calle R, McCarthy MI, Banerjee P, Zeggini E, Cull CA, Thorne KI, Wiltshire S, Terra S, Meyer D, Richmond J, Mancuso J, Milos P, Fryburg D, Holman RR Diabetologia 2006;49:2892-2899 [Full text] [Abstract]

	UKPDS Letter Is there a need for a clinical screening tool for autoimmune diabetes in adults? Davis TME, Cull CA, Holman RR Diabetes Care 2006;11:2560 [Full text]

	UKPDS 73 Hypoglycemia in Type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS 73 Wright AD, Cull CA, Macleod KM, Holman RR for the UKPDS Group Journal of Diabetes and its Complications 2006;20:402-408 [Full text] [Abstract]

	UKPDS 75 Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study Stratton IM, Cull CA, Adler AI, Matthews DR, Neil HA, Holman RR Diabetologia 2006;49:1761-1769 [Full text] [Abstract]

	UKPDS 74 Risk Factors for Renal Dysfunction in Type 2 Diabetes Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR for the UKPDS study group Diabetes 2006;55:1832-1839 [Full text] [Abstract]

	UKPDS Long-term efficacy of sulfonylureas: a United Kingdom Prospective Diabetes Study perspective Holman RR Metabolism Clinical and Experimental 2006;55 (Suppl 1):S2-S5 [Full text] [Abstract]

	UKPDS The Variable Number of Tandem Repeats Upstream of the Insulin Gene Is a Susceptibility Locus for Latent Autoimmune Diabetes in Adults Desai M, Zeggini E, Horton VA, Owen KR, Hattersley AT, Levy JC, Hitman GA, Walker M, Holman RR, McCarthy MI, Clark A Diabetes 2006;55:1890-1894 [Full text] [Abstract]

2005	Outcomes Model / UKPDS 72 Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72) Clarke PM, Gray AM, Briggs A, Stevens RJ, Matthews DR, Holman RR Diabetologia 2005;48:868-877 [Full text]

	UKPDS 71 IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes G. F. Bottazzo, E. Bosi, C. A. Cull, E. Bonifacio, M. Locatelli, P. Zimmet, I. R. Mackay, R. R. Holman Diabetologia 2005;48:703-708 [Full text] Erratum in : Diabetologia 2005;48:1240

	UKPDS 70 Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control T. M. E. Davis, A. D. Wright, Z. M. Mehta, C. A. Cull, I. M. Stratton, G. F. Bottazzo, E. Bosi, I. R. Mackay, R. R. Holman Diabetologia 2005;48:695-702 [Full text]

	UKPDS Reporting of diabetes on death certificates using data from the UK Prospective Diabetes Study Thomason MJ, Biddulph JP, Cull CA, Holman RR Diabetic Medicine 2005;22:1031-1036 [Full text]

2004	UKPDS 69 Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus Matthews DR, Stratton IM, Aldington SJ, Holman RR, Kohner EM for the UK Prospective Diabetes Study Group Archives of Ophthalmology 2004;122:1631-1640 [Full text]

	Outcomes Model / UKPDS 68 A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS 68) P. M. Clarke, A. M. Gray, A. Briggs, A. J. Farmer, P. Fenn, R. J. Stevens, D. R. Matthews, I. M. Stratton, R. R. Holman Diabetologia 2004;47:1747-1759 [Full text]

	UKPDS 67 Insulin sensitivity at diagnosis of Type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS 67) Adler AI, Levy JC, Matthews DR, Stratton IM, Hines G, Holman RR Diabetic Medicine 2004;22:306-311 [Full text] [Abstract]

	Risk Engine / UKPDS 66 Risk Factors for Myocardial Infarction Case Fatality and Stroke Case Fatality in Type 2 Diabetes Stevens RJ, Coleman RL, Adler AI, Stratton IM, Matthews DR, Holman RR Diabetes Care 2004;27:201-207 [Abstract]

	UKPDS Changing aspirin use in patients with Type 2 diabetes in the UKPDS Cull CA, Neil HAW, Holman RR Diabetic Medicine 2004;21:1368-1371 [Full text] [Abstract]

2003	Outcomes Model / UKPDS 65 The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No 65) Clarke P, Gray A, Legood R, Briggs A, Holman R Diabetic Medicine 2003;20:442-450 [Full text]

	UKPDS 64 Development and Progression of Nephropathy in Type 2 Diabetes: Observation and Modelling from the United Kingdom Prospective Diabetes Study Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR for the UKPDS Group Kidney International 2003;63:225-232 [Abstract]

	UKPDS Autoantibodies to the islet cell antigen SOX-13 areassociated with duration but not type of diabetes Davis TM, Mehta Z, Mackay IR, Cull CA, Bruce DG, Fida S, Rowley MJ, Holman RR Diabetic Medicine 2003;20:198-204 [Abstract]

	UKPDS Poor pregnancy outcome for women with Type 2 diabetes Hadden DR, Cull CA, Croft DJ, Holman RR Diabetic Medicine 2003;20:506-507

2002	UKPDS 63 The economics of translating trial evidence into practice: costs of implementing more intensive glycaemic and blood pressure control in type 2 diabetes in England Gray A, Clarke P, Farmer A, Holman R for the United Kingdom Prospective Diabetes Study (UKPDS) Group British Medical Journal 2002;325:1-6 [Full text] [Abstract]

	Outcomes Model / UKPDS 62 Estimating utility values for health states of type 2 diabetic patients using the EQ-5D Clarke P, Gray A, Holman R Medical Decision Making 2002;4:340-349

	UKPDS 61 Are Lower Fasting Plasma Glucose Levels at Diagnosis of Type 2 Diabetes Associated with Improved Outcomes? Colagiuri S, Cull CA, Holman RR Diabetes Care 2002;25:1410-1417 [Abstract]

	Risk Engine / UKPDS 60 Risk of stroke in type 2 diabetes estimated by the UKPDS risk engine Kothari V, Stevens RJ, Adler AI, Stratton IM, Manley SE, Neil HA, Holman RR Stroke 2002;33:1776-1781 [Abstract]

	UKPDS 59 Hyperglycemia and Other Potentially Modifiable Risk Factors for Peripheral Vascular Disease in Type 2 Diabetes. Adler AI, Stevens RJ, Neil A, Stratton IM, Boulton AJ, Holman RR Diabetes Care 2002;25:894-899 [Abstract]

	UKPDS 58 Modeling glucose exposure as a risk factor for photocoagulation in type 2 diabetes. Stevens RJ, Stratton IM, Holman RR. Journal of Diabetes and its Complications 2002;16:371-376 [Abstract]

	UKPDS 57 Sulfonylurea Inadequacy: Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK Prospective Diabetes Study Wright A, Burden ACF, Paisey RB, Cull CA, Holman RR. Diabetes Care 2002;25:330-336 [Abstract] Erratum in : Diabetes Care 2002;25:1268

	UKPDS Analysis of the United Kingdom Prospective Diabetes Study Holman RR Endocrine Practice 2002;8:33-34 [Abstract]

	UKPDS Letter Calculation of coronary risk in Type 2 diabetes: another cause for concern: authors' reply Holman RR, Manley SE, Stevens RJ on behalf of the UKPDS Study Group Clinical Science 2002;103:217-219

	UKPDS Standardization of glycated haemoglobin. Marshall SM, Home PD, Manley SM, Barth JH, John WG. Annals of Clinical Biochemistry 2002;39:77-79

2001	Risk Engine / UKPDS 56 The UKPDS Risk Engine: a model for the risk of coronary heart disease in type 2 diabetes Stevens RJ, Kothari V, Adler AI, Stratton IM; United Kingdom Prospective Diabetes Study (UKPDS) Group Clinical Science 2001;101:671-679 [Abstract] Erratum in : Clinical Science 2002;102:679

	UKPDS 55 Relationship between ethnicity and glycaemic control, lipid profiles and blood pressure during the first nine years of Type 2 diabetes Davis TM, Cull CA, Holman RR; U.K. Prospective Diabetes Study (UKPDS) Group Diabetes Care 2001;24:1167-1173 [Abstract]

	UKPDS 54 An economic evaluation of atenolol versus captopril in patients with Type 2 diabetes Gray A, Clarke P, Raikou M, Stevens R, Neil A, Cull C, Stratton I, Holman R Diabetes Medicine 2001;18:438-444 [Abstract]

	UKPDS 53 Association Studies of Variants in Promotor and Coding regions of b-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 Diabetes Gloyn AL, Hashim Y, Ashcroft SJ, Ashfield R, Wiltshire S, Turner RC. Diabetic Medicine 2001;18:206-12 [Abstract]

	UKPDS 52 Relationship between severity of retinopathy and progression to photocoagulation in type 2 diabetic patients in UKPDS. Kohner EM, Stratton IM, Aldington SJ, Holman RR, Matthews DR. Diabetic Medicine 2001;18:178-184 [Abstract]

	UKPDS 50 Risk factors for incidence and progression of retinopathy in type 2 diabetes over 6 years from diagnosis. Stratton IM, Kohner EM, Aldington SJ, Turner RC, Manley SE, Matthews DR Diabetologia 2001;44:1546-163 [Abstract]

	UKPDS Butyrylcholinesterase K variant on chromsome 3q is associated with Type II diabetes in white Caucasian subjects Hashim Y, Shepherd D, Wiltshire S, Holman RR, Levy JC, Clark A, et al. Diabetologia 2001;44:2227-2230 [Abstract] Erratum in : Diabetologia 2002;45:459

	UKPDS The UKPDS: implications for the dyslipidaemic patient Holman R Acta Diabetologica 2001;38:S9-S14 [Abstract]

	UKPDS Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies. Clarke R, Lewington S, Donald A, Johnston C, Refsum H, Stratton IM, Jacques P, Breteler MMB, Holman R Journal of Cardiovascular Risk 2001;8:363-369 [Abstract]

	UKPDS 51 Cost-effective analysis of intensive blood glucose control with metformin in overweight patients with type 2 diabetes (UKPDS 51). Clarke P, Gray A, Adler A, Stevens R, Raikou M, Cull C, Stratton I, Holman R; UKPDS Group. United Kingdom Prospective Diabetes Study Diabetologia 2001;44:298-304 [Abstract]

2000	UKPDS 35 Association of glycaemia with macrovascular and microvascular complications of Type 2 diabetes: prospective observational study. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR British Medical Journal 2000;321:405-412 [Full text] [Abstract] [Slides]

	UKPDS Life-expectancy projection by modelling and computer simulation (UKPDS 46). Stevens R, Adler A, Gray A, Briggs A, Holman R. Diabetes Research and Clinical Practice 2000;50:S5-S13 [Abstract]

	UKPDS 45 Effects of three months' diet after diagnosis of type 2 diabetes on plasma lipids and lipoproteins Manley SM, Stratton IM, Cull CA, Fighi V, Eeley EA, Matthews DR, Holman RR, Turner RC Diabetic Medicine 2000;17:518-523 [Abstract]

	UKPDS 36 Association of systolic blood pressue with macrovascular and microvascular complications of Type 2 diabetes: prospective observational study Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, Wright AD, Turner RC, Holman RR British Medical Journal 2000;321:412-419 [Full text] [Abstract] [Slides] [Slides #2]

	UKPDS Letter Seeing what you want to see in randomised controlled trials. Authors' choice of study was ill informed Holman RR British Medical Journal 2000;321:1078-1079 [Full text] [Abstract]

	UKPDS 41 Cost-effective analysis of intensive blood glucose control with metformin in overweight patients with type 2 diabetes. Gray A, Raikou M, McGuire A, Fenn P, Stevens R, Cull C, Stratton I, Adler A, Holman R, Turner R British Medical Journal 2000;320:1373-1378 [Full text] [Abstract]

1999	UKPDS 49 Glycaemic control with diet, sulphonylurea, metformin and insulin therapy in patients with type 2 diabetes: progressive requirement for multiple therapies Turner RC, Cull CA, Frighi V, Holman RR JAMA 1999;281:2005-2012 [Abstract]

	UKPDS 48 Sequence variants of the sarco(endo)plasmic reticulum Ca2+-transport ATPase 3 gene (SERCA3) are associated with Type 2 diabetes in Caucasians Varadi A, Lebel L, Hashim Y, Mehta Z, Ashcroft SJH, Turner RC Diabetologia 1999;42:1240-1243 [Full text] [Abstract]

	UKPDS 47 Hyperglycaemia and hyperinsulinaemia at diagnosis of diabetes and their association to subsequent cardiovascular disease in the UK Prospective Diabetes Study Adler AI, Neil AW, Manley SE, Holman RR, Turner RC American Heart Journal 1999;138:S353-S359 [Abstract]

	UKPDS 44 Randomised, double-blind trial of acarbose in type 2 diabetes shows improved glycaemic control over three years Holman RR, Cull CA, Turner RC Diabetes Care 1999;22:960-964 [Abstract] Erratum in : Diabetes Care 1999;22:1922

	UKPDS 43 Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes Horton VA, Stratton IM, Bottazzo GF, Shattock M, MacKay I, Zimmett P, Manley SE, Holman RR, Turner RC Diabetologia 1999;42:608-616 [Abstract]

	UKPDS 42 Microaneurysms in the development of diabetic retinopathy Kohner EM, Stratton IM, Adlington SJ, Turner RC Diabetologia 1999;42:1107-1112 [Abstract]

	UKPDS 37 Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control UKPDS Group Diabetes Care 1999;22:1125-1136 [Abstract]

	UKPDS 31 Hepatocyte nuclear factor-1a (the MODY3 gene) mutations in late onset Type 2 diabetes in the UK. Cox RD, Sotham L, Hashim Y, Horton V, Mehta Z, Taghavi J, Lathrop M, Turner RC Diabetes 1999;42:120-121

	UKPDS 29 Risk factors for stroke in non-insulin dependent diabetes mellitus Davies TME, Millns H, Stratton IM, Holman RR, Turner RC Archives of Internal Medicine 1999;159:1097-1103 [Abstract]

	UKPDS UKPDS: What was the question? UK Prospective Diabetes Study Turner R, Holman R, Butterfield J Lancet 1999;354:600

1998	UKPDS 40 Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes UKPDS Group British Medical Journal 1998;317:720-726 [Full text] [Abstract]

	UKPDS 39 Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes UKPDS Group British Medical Journal 1998;317:713-720 [Full text] [Abstract]

	UKPDS 38 Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes UKPDS Group British Medical Journal 1998;317:703-713 [Full text] [Abstract]

	UKPDS 34 Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes UKPDS Group Lancet 1998;352:854-865 [Abstract] Erratum in : Lancet 1998;352:1558

	UKPDS 33 Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes UKPDS Group Lancet 1998;352:837-853 [Abstract] Erratum in : Lancet 1999;354:602

	UKPDS 32 Ethnicity and cardiovascular disease: the incidence of myocardial infarction in white, south Asian and Afro-Caribbean patients with Type 2 diabetes UKPDS Group Diabetes Care 1998;21:1271-1277 [Abstract]

	UKPDS 30 Diabetic retinopathy at diagnosis of type 2 diabetes and associated risk factors UKPDS Group Archives of Ophthalmology 1998;116:297-303 [Abstract]

	UKPDS 28 A randomised trial of efficacy of early addition of metformin in sulphonylurea-treated non-insulin dependent diabetes UKPDS Group Diabetes Care 1998;21:87-92 [Abstract]

	UKPDS 26 Sulphonylurea failure in non-insulin dependent diabetic patients over 6 years Matthews DR, Cull CA, Stratton IM, Holman RR, Turner RC Diabetic Medicine 1998;15:297-303 [Abstract]

	UKPDS 24 Relative efficacy of sulfonylurea, insulin and metformin therapy in newly diagnosed non-insulin dependent diabetes with primary diet failure followed for six years UKPDS Group Annals of internal medicine 1998;128:165-175 [Abstract]

	UKPDS 23 Risk factors for coronary artery disease in non-insulin dependent diabetes UKPDS Group British Medical Journal 1998 1998;316:823-828 [Abstract]

1997	UKPDS 27 Plasma lipids and lipoproteins at diagnosis of NIDDM: effects of age and gender UKPDS Group Diabetes Care 1997;20:1683-1687 [Abstract]

	UKPDS 25 Autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes UKPDS Group Lancet 1997;350:1288-1293 [Abstract]

	UKPDS 22 Effect of age at diagnosis on diabetic tissue damage during the first 6 years of NIDDM UKPDS Group Diabetes Care 1997;20:1435-1441 [Abstract]

	UKPDS 21 Low prevalence of the mitochondrial transfer RNA gene (tRNA Leu(UUR)) mutation at position 3243bp in UK Caucasian Type 2 diabetic patients Saker PJ, Hattersley AT, Barrow B, Hammersley MS, Vorton H, Gillmer MD, Turner RC Diabetic Medicine 1997;14:42-45 [Abstract]

	UKPDS 20 Plasma leptin, obesity and plasma insulin in type 2 diabetic subjects. UKPDS Group Journal of Clinical Endocrinology & Metabolism 1997;82:654-657 [Abstract]

	UKPDS Progressive Hyperglycaemia: the UKPDS Experience Holman RR Consultant (Supp) 1997;37:530-536 [Abstract]

1996	UKPDS 18 Estimated dietary intake in type 2 diabetic patients randomly allocated to diet, sulphonylurea or insulin therapy UKPDS Group Diabetic Medicine 1996;13:656-662 [Abstract]

	UKPDS 17 A nine-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus UKPDS Group Annals of Internal Medicine 1996;124:136-145 [Abstract]

	UKPDS The UK Prospective Diabetes Study Turner RC, Holman RR Annals of Medicine 1996;28:439-444 [Abstract]

	UKPDS U.K. Prospective Diabetes Study Turner RC, Cull CA, Holman RR Diabetes Care 1996;19:182-183

1995	UKPDS 16 Overview of six years' therapy of type 2 diabetes - a progressive disease UKPDS Group Diabetes 1995;44:1249-1258 [Abstract]

	UKPDS 15 Relation of renin/angiotensin system gene polymorphisms with microalbuminuria in non-insulin dependent diabetes mellitus Dudley CRK, Keavney B, Stratton IM, Turner RC Kidney International 1995;48:1907-1911 [Abstract]

	UKPDS 14 Association of ACE insertion/deletion polymorphism with myocardial infarction in non-insulin dependent diabetes (NIDDM) Keavney BD, Dudley CRK, Stratton IM, Holman RR, Matthews DR, Ratcliffe PJ, Turner RC Diabetologia 1995;38:948-952 [Abstract]

	UKPDS 13 Relative Efficacy of Randomly allocated Diet, Sulphonylurea, Insulin, or Metformin in Patients with newly diagnosed non-insulin dependent diabetes followed for three years Holman RR, Cull CA, Fox C, Turner RC British Medical Journal 1995;310:83-88 [Full text] [Abstract]

	UKPDS UK Prospective Diabetes Study: 3-year update Holman RR for the UKPDS Group New Horizons in Diabetes Mellitus and Cardiovascular Disease, Current Science Press. Ed Born GVR, Schwartz J. 1995;183-186

	UKPDS Lessons from UK Prospective Diabetes Study Turner RC, Holman RR Diabetes Research and Clinical Practice 1995;28:S151-S157 [Abstract]

1994	UKPDS 12 Differences between Asian, Afro-Caribbean and white Caucasian type 2 diabetic patients at diagnosis of diabetes Meyer LC, Manley SE, Frighi V, Burden F, Neil HAW, Holman RR, Turner RC Diabetic Medicine 1994;11:670-677 [Abstract]

	UKPDS 11 Biochemical risk factors in type 2 diabetic patients at diagnosis compared with age-matched normal subjects Manley SE, Meyer LC, Neil HAW, Ross IS, Turner RC, Holman RR Diabetic Medicine 1994;11:534-544 [Abstract]

1993	UKPDS 9 Relationships of urinary albumin and N-acetylglucosaminidase to glycaemia and hypertension at diagnosis of type 2 (non-insulin-dependent) diabetes mellitus and after 3 months diet therapy UKPDS Study Group Diabetologia 1993;36:835-842 [Abstract]

	UKPDS 10 Urinary albumin excretion over 3 years in diet-treated Type 2 (non-insulin-dependent) diabetic patients, and association with hypertension, hyperglycaemia and hypertriglyceridaemia Cull CA, Manley S, Frighi V, Holman RR, Turner RC Diabetologia 1993;36:1021-1029 [Abstract]

	UKPDS L'Etude UKPDS Sur Le Controle De La Glycemie Et De L'Hypertension Arterielle Dans Le Diabete De type 2: Objectifs, Structure Et Resultats Preminiaires Levy JC, Cull CA, Stratton IM, Holman RR, Turner RC Journ Annu Diabetol Hotel Dieu 1993;123-37

1991	UKPDS 8 Study design, progress and performance Turner RC, Holman RR, Matthews DR, Oakes SF, Bassett PA, Stratton IM, Cull CA, Manley SE, Frighi V Diabetologia 1991;34:877-890 [Abstract]

1990	UKPDS 7 Response of fasting plasma glucose to diet therapy in newly-presenting Type 2 diabetic patients UKPDS Study Group Metabolism 1990;39:905-912 [Abstract]

	UKPDS 6 Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors UKPDS Study Group Diabetes Research 1990;13:1-11 [Abstract]

1988	UKPDS 5 Characteristics of newly presenting type 2 diabetic patients: estimated insulin sensitivity and islet beta-cell function UKPDS Study Group Diabetic Medicine 1988;5:444-448 [Abstract]

	UKPDS 4 Characteristics of newly-presenting type 2 diabetic patients: male preponderance and obesity at different ages UKPDS Study Group Diabetic Medicine 1988;5:154-159 [Abstract]

1985	UKPDS 3 Prevalence of hypertension and hypotensive therapy in patients with newly diagnosed diabetes UKPDS Study Group Hypertension 1985;7:11-13 [Abstract]

	UKPDS 2 Reduction in HbA1c with basal insulin supplement, sulphonylurea, or biguanide therapy in maturity-onset diabetes UKPDS Study Group Diabetes 1985;34:793-798 [Abstract]

1983	UKPDS 1 Effect of diet, sulphonylurea, insulin or biguanide therapy on fasting plasma glucose and body weight over one year UKPDS Study Group Diabetologia 1983;24:404-411 [Abstract]